To visually evaluate the retention of coverage of the Test Product(s) (TP) on the face after exercise compared to the full coverage observed prior to exercise.

Inclusion Criteria:

• Subjects may be male or female, of an age of 18-55 years inclusive.
• Subjects must be capable of understanding and providing written informed consent.
• Subjects must sign a written confidentiality agreement including a photography release form.
• Subjects must be in good general health as judged by a specified licensed physician, who will indicate their suitability to participate in this study.
• Female subjects must be willing to take a rapid screen pregnancy test prior to each exercise session.
• Subjects must be willing to follow study instructions as set forth in the protocol.
• Subjects must not have facial piercing(s).
• Subjects must be Fitzpatrick Skin Type I, II, or III.

Exclusion Criteria:

• Subjects must not have received or used an Investigational New Drug within the last 30 days.
• Subjects must not have been active participants in another clinical or subjective TP performance study within the last 30 days unless authorized by this Sponsor.
• Subjects must not have a known physical or medical condition that would preclude vigorous exercise
• Subjects must not have a five-minute resting pulse rate greater than 80 bpm.
• Subjects must not take any chronic medication other than vitamins, hormone replacement therapy, low-dose aspirin, or oral contraceptives.
• Subjects must not have applied prescription or over-the-counter medicines to their face at least 96 hours prior to exercise session
• Subjects must not have a known allergy or sensitivity to sunscreen products or Cetaphil cleanser.
• Female subjects must not be pregnant (self-reported) or test positive using an on-site pregnancy test.
• Female subjects must not be nursing a child.
• Subjects must not have smoked cigarettes, pipes, or cigars in the last 60 days.
• Subjects who in the judgment of the Investigator have any condition that would make study participation inappropriate.
• Subjects must not be a member or relative of the clinical trial staff or the Sponsor directly involved in the study.